Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas.

Bibliographic Details
Title: Plasma lipoxin A4 and resolvin D1 are not associated with reduced adenoma risk in a randomized trial of aspirin to prevent colon adenomas.
Authors: Fedirko, Veronika, McKeown‐Eyssen, Gail, Serhan, Charles N., Barry, Elizabeth L., Sandler, Robert S., Figueiredo, Jane C., Ahnen, Dennis J., Bresalier, Robert S., Robertson, Douglas J., Anderson, Carlton W., Baron, John A.
Source: Molecular Carcinogenesis; Aug2017, Vol. 56 Issue 8, p1977-1983, 7p
Database: Complementary Index
More Details
ISSN:08991987
DOI:10.1002/mc.22629
Published in:Molecular Carcinogenesis
Language:English